When to Order Imaging for Suspected Pulmonary Hypertension: ACR Appropriateness Decoded
When to Order Imaging for Suspected Pulmonary Hypertension: ACR Appropriateness Decoded
A patient presents with progressive dyspnea on exertion, fatigue, and lower extremity edema. Their oxygen saturation is borderline, and you hear an accentuated P2 on exam. The differential is broad, but pulmonary hypertension (PH) is high on the list. The immediate question is what imaging to order first. Should you start with a chest radiograph, go straight to a transthoracic echocardiogram (TTE), or order a CT angiogram to rule out pulmonary embolism? Making the right initial choice is critical for timely diagnosis and avoiding unnecessary radiation or invasive procedures. This guide breaks down the American College of Radiology (ACR) Appropriateness Criteria for the initial imaging workup of suspected pulmonary hypertension, providing a clear, evidence-based framework for your next order.
What Does ACR Suspected Pulmonary Hypertension Cover?
The ACR Appropriateness Criteria for Suspected Pulmonary Hypertension focus specifically on the initial, non-invasive imaging evaluation for adult and pediatric patients in whom the diagnosis is being considered for the first time. This guideline applies to individuals presenting with signs or symptoms suggestive of PH, such as unexplained shortness of breath, exertional intolerance, syncope, or clinical signs of right heart failure. The primary goal of this initial imaging is to detect the presence of PH, assess its potential severity, evaluate its impact on the right heart, and identify potential underlying causes like interstitial lung disease or chronic thromboembolic disease.
This topic does not apply to patients with an already established diagnosis of pulmonary hypertension who require follow-up imaging to monitor disease progression or response to therapy. It also does not cover the use of invasive diagnostic procedures like right heart catheterization as a first-line step, as these are typically reserved for confirming the diagnosis and guiding therapy after initial non-invasive imaging raises high suspicion.
What Imaging Should I Order for Suspected Pulmonary Hypertension? Recommendations by Clinical Scenario
For the initial imaging workup of a patient with suspected pulmonary hypertension, the ACR provides clear guidance to streamline the diagnostic process. The recommendations prioritize non-invasive studies that can provide comprehensive information about cardiac structure, right ventricular function, and pulmonary vascular and parenchymal anatomy.
First-Line and Foundational Imaging
For the initial evaluation, a Resting Transthoracic Echocardiogram (TTE) is rated as Usually Appropriate. TTE is the cornerstone of the non-invasive workup, allowing for estimation of the pulmonary artery systolic pressure (PASP), assessment of right ventricular size and function, and detection of other cardiac abnormalities that could cause or coexist with PH. A Chest Radiograph is also Usually Appropriate. While often non-specific, it is a valuable, low-dose initial test that can reveal signs of PH, such as enlarged central pulmonary arteries or right heart enlargement, and may identify alternative causes for the patient’s symptoms, like significant interstitial lung disease or cardiomegaly.
Advanced Anatomic and Vascular Evaluation
When more detailed anatomic information is needed, particularly to evaluate for chronic thromboembolic pulmonary hypertension (CTEPH) or underlying lung disease, both CT Chest with IV Contrast and CTA Chest with IV Contrast are rated as Usually Appropriate. These studies provide excellent visualization of the lung parenchyma, mediastinum, and pulmonary arteries, making them essential for identifying chronic thrombus, interstitial changes, or other structural causes of PH.
Conditional and Problem-Solving Modalities
Several other studies are rated as May be Appropriate depending on the clinical context. A Transesophageal Echocardiogram (TEE) may be useful if the image quality from a TTE is suboptimal. Cardiac MRI (with or without contrast) is an excellent problem-solving tool for providing precise, quantitative assessment of right and left ventricular size, mass, and function when echocardiography is inconclusive. A V/Q Scan also May be Appropriate, though the panel noted disagreement; its primary role is as a screening tool for CTEPH, particularly in patients for whom a CTA is contraindicated or inconclusive.
Studies Not Recommended for Initial Workup
Invasive studies like Right Heart Catheterization and Pulmonary Arteriography are Usually Not Appropriate for the *initial* imaging evaluation, as they are reserved for confirming the diagnosis and are not first-line screening tools. Similarly, non-contrast CT, CT with and without contrast, and MRA of the chest are generally less informative than a dedicated contrast-enhanced CT or CTA in this initial diagnostic phase and are therefore rated as Usually Not Appropriate.
ACR Imaging Recommendations Table
| Clinical Scenario | Top Procedure | ACR Rating | Adult RRL | Pediatric RRL |
|---|---|---|---|---|
| Suspected pulmonary hypertension. Initial imaging. | US echocardiography transthoracic resting | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | Radiography chest | Usually appropriate | ☢ <0.1 mSv | ☢ <0.03 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | CT chest with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | CTA chest with IV contrast | Usually appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | US echocardiography transesophageal | May be appropriate | O 0 mSv | O 0 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | MRI heart function and morphology without and with IV contrast | May be appropriate | O 0 mSv | O 0 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | MRI heart function and morphology without IV contrast | May be appropriate | O 0 mSv | O 0 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | V/Q scan lung | May be appropriate (Disagreement) | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ 0.3-3 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | Catheterization right heart | Usually not appropriate | ☢ ☢ 0.1-1mSv | |
| Suspected pulmonary hypertension. Initial imaging. | Arteriography pulmonary with right heart catheterization | Usually not appropriate | ☢ ☢ ☢ ☢ 10-30 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | MRA chest without and with IV contrast | Usually not appropriate | O 0 mSv | O 0 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | MRA chest without IV contrast | Usually not appropriate | O 0 mSv | O 0 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | CT chest without and with IV contrast | Usually not appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
| Suspected pulmonary hypertension. Initial imaging. | CT chest without IV contrast | Usually not appropriate | ☢ ☢ ☢ 1-10 mSv | ☢ ☢ ☢ ☢ 3-10 mSv [ped] |
Adult vs. Pediatric Suspected Pulmonary Hypertension Imaging: Radiation Dose Tradeoffs
While the primary diagnostic algorithm for suspected pulmonary hypertension is similar between adults and children, radiation safety is a paramount concern in the pediatric population. The principle of ALARA (As Low As Reasonably Achievable) guides imaging choices, prioritizing modalities that do not use ionizing radiation whenever possible. Transthoracic echocardiography and cardiac MRI are particularly valuable in children as they are radiation-free and provide excellent functional and anatomical data.
When radiation is necessary, protocols are carefully optimized to minimize exposure. The ACR notes different relative radiation levels (RRL) for several key studies. For instance, a pediatric chest CT or CTA is assigned a higher RRL category (☢ ☢ ☢ ☢) than the adult equivalent (☢ ☢ ☢), reflecting the increased lifetime attributable risk of radiation in younger patients. Conversely, a pediatric V/Q scan has a lower RRL than the adult study. These differences underscore the importance of tailoring the imaging workup to the individual child, weighing the diagnostic need for studies like CT against the cumulative radiation dose and considering radiation-free alternatives first.
Imaging Protocol Details for Suspected Pulmonary Hypertension
Choosing the right imaging study is the first step; ensuring it is performed with the correct technique is just as critical for an accurate diagnosis. A suboptimal protocol can obscure key findings or lead to non-diagnostic results. For detailed, modality-specific guidance on technique, contrast administration, and acquisition parameters for the studies recommended in this article, clinicians and technologists should consult standardized institutional protocols. The GigHz Imaging Protocol Library serves as a comprehensive resource for establishing and reviewing best-practice imaging techniques for a wide range of cardiovascular and thoracic studies.
Tools to Help You Order the Right Study
Navigating imaging guidelines and radiation safety can be complex. GigHz provides a suite of tools designed to support evidence-based clinical decision-making at the point of care.
For clinical questions beyond suspected pulmonary hypertension, the ACR Appropriateness Criteria Lookup tool provides direct access to the full library of ACR guidelines, covering thousands of clinical scenarios across all specialties. This helps you quickly find the most appropriate imaging for virtually any presentation.
Once a study is chosen, the Imaging Protocol Library offers detailed, step-by-step protocols for performing a wide variety of diagnostic imaging exams, ensuring high-quality, consistent results.
To help manage and communicate radiation exposure with patients, the Radiation Dose Calculator allows for estimation of effective dose from common imaging studies, supporting informed consent and adherence to the ALARA principle.
Frequently Asked Questions about Imaging for Suspected Pulmonary Hypertension
Here are common questions clinicians have when ordering imaging for patients with suspected PH.
Why is a transthoracic echocardiogram (TTE) the recommended first step?
A TTE is the primary screening tool because it is non-invasive, widely available, uses no radiation, and provides a wealth of information. It can estimate pulmonary artery pressures, assess the size and function of the right ventricle, evaluate for valvular heart disease, and detect intracardiac shunts—all of which are critical pieces of the initial diagnostic puzzle.
When should I order a CT or CTA instead of or in addition to an echocardiogram?
A CT or CTA is often complementary to an echocardiogram. It is particularly valuable when you need to evaluate the lung parenchyma for interstitial lung disease or the pulmonary arteries for signs of chronic thromboembolic pulmonary hypertension (CTEPH). If the chest radiograph shows significant lung disease or if CTEPH is a leading consideration, a CTA may be ordered early in the workup, often in parallel with the TTE.
What is the role of a V/Q scan, and why is there panel disagreement?
A ventilation/perfusion (V/Q) scan is a highly sensitive test for detecting the mismatched perfusion defects characteristic of CTEPH. It is rated as “May be Appropriate” and is often used as a screening tool for CTEPH, especially if a patient has a contraindication to CT contrast. The panel disagreement may reflect the increasing use and diagnostic accuracy of CTA, which not only diagnoses CTEPH but also provides detailed anatomic information about the thrombus burden and lung parenchyma that a V/Q scan cannot.
Is right heart catheterization (RHC) ever appropriate?
Yes, but not for the initial suspicion. RHC is the gold standard for *confirming* the diagnosis of pulmonary hypertension, accurately measuring pulmonary pressures, assessing vasoreactivity, and calculating pulmonary vascular resistance. The ACR criteria rate it as “Usually Not Appropriate” for the *initial imaging workup* because non-invasive tests should be performed first. Once TTE or other imaging suggests a high probability of PH, RHC is the essential next step to confirm the diagnosis and guide specific therapy.
Why is a non-contrast chest CT considered “Usually Not Appropriate” for this indication?
A non-contrast CT of the chest is limited in this context. While it can assess the lung parenchyma for interstitial disease and show secondary signs of PH like enlarged pulmonary arteries, it cannot evaluate for intraluminal filling defects seen in CTEPH. A contrast-enhanced study (CT or CTA) provides significantly more diagnostic information by visualizing the pulmonary vasculature and heart chambers, making it the superior choice for a comprehensive initial evaluation.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026
